NEW YORK (GenomeWeb) – Startup molecular diagnostic firm Prominex announced today it has raised $4 million in Series A1 financing. 

The funding comes from Casdin Capital and Paul Thomas, a cofounder and CEO of Prominex and former CEO of Roka Bioscience. 

Prominex will use the funding to further develop its technology — including a coupled hairpin amplification system, or CHASE, and waveguide detection — for highly multiplexed infectious disease assays, in partnership with point-of-care instrument developer Invetech.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.